{"transactions":[{"id":3609898,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:01:59.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":26865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 8,955 vesting on each of March 4, 2021, March 4, 2022 and  March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 8,955 vesting on each of March 4, 2021, March 4, 2022 and  March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":26865,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26865},"source":{"system":"sec-edgar","filing":"0001209191-19-017225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017225/doc4.xml","form_type":"4"}},{"id":3651762,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Restricted Share Units","published_at":"2019-02-19T11:58:50.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":3212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 14, 2017, with 3,212 vesting on each of February 14, 2019 and February 14, 2020 and 3,213 vesting on February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 14, 2017, with 3,212 vesting on each of February 14, 2019 and February 14, 2020 and 3,213 vesting on February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6425,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3212},"source":{"system":"sec-edgar","filing":"0001209191-19-010833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010833/doc4.xml","form_type":"4"}},{"id":3651761,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Ordinary Shares","published_at":"2019-02-19T11:58:50.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":3212,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":17996.0357,"source":{"system":"sec-edgar","filing":"0001209191-19-010833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010833/doc4.xml","form_type":"4"}},{"id":3658623,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Ordinary Shares","published_at":"2019-02-14T12:40:04.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":6494,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Ordinary Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units."}],"balance_after":14784.0357,"source":{"system":"sec-edgar","filing":"0001209191-19-009988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119009988/doc4.xml","form_type":"4"}},{"id":3846627,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Ordinary Shares","published_at":"2018-08-13T12:34:39.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":4165,"price":22.699,"value":94541.335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Ordinary Shares were sold in New Israeli Shekels. The price shown is calculated based on the exchange rate of NIS 3.683 per $1.00, as published by the Bank of Israel on August 9, 2018."}],"balance_after":8290.0357,"source":{"system":"sec-edgar","filing":"0001209191-18-046335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118046335/doc4.xml","form_type":"4"}},{"id":4067063,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:29:52.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":34031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 11,343 vesting on each of February 9, 2020 and February 9, 2021 and 11,345 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 11,343 vesting on each of February 9, 2020 and February 9, 2021 and 11,345 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":34031,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34031},"source":{"system":"sec-edgar","filing":"0001209191-18-009214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009214/doc4.xml","form_type":"4"}},{"id":4067062,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":159423,"kind":"person","name":"Codner Iris Beck","position":1,"cik":"0001721514","reported_name":"Codner Iris Beck","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Brand&Communication"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:29:52.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":86762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 28,920 vesting on each of February 9, 2020 and February 9, 2021 and 28,922 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":86762,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":86762},"source":{"system":"sec-edgar","filing":"0001209191-18-009214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009214/doc4.xml","form_type":"4"}}]}